Darwin Global Management as of March 31, 2021
Portfolio Holdings for Darwin Global Management
Darwin Global Management holds 12 positions in its portfolio as reported in the March 2021 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Acceleron Pharma | 40.0 | $204M | 1.5M | 135.61 | |
| Bridgebio Pharma (BBIO) | 25.2 | $129M | 2.1M | 61.60 | |
| Fate Therapeutics (FATE) | 22.1 | $113M | 1.4M | 82.45 | |
| Relay Therapeutics (RLAY) | 5.3 | $27M | 783k | 34.57 | |
| Arvinas Ord (ARVN) | 1.8 | $9.3M | 141k | 66.10 | |
| Macrogenics (MGNX) | 1.8 | $9.1M | 286k | 31.85 | |
| Generation Bio (GBIO) | 1.2 | $6.2M | 219k | 28.46 | |
| Keros Therapeutics (KROS) | 1.0 | $5.3M | 87k | 61.55 | |
| C4 Therapeutics Com Stk (CCCC) | 1.0 | $5.2M | 140k | 36.99 | |
| Immunovant (IMVT) | 0.2 | $1.1M | 66k | 16.04 | |
| Inhibrx | 0.2 | $998k | 50k | 20.08 | |
| Fulcrum Therapeutics (FULC) | 0.1 | $587k | 50k | 11.77 |
